Technology
Nordic Vaccine has developed a skin patch system (TransVac™) for efficient, needle free administration of vaccines. The system combines Nordic Vaccine's nanotechnology platform (Posintro™) with an adhesive patch and gel technology developed by Coloplast. Nordic Vaccine does vaccine research based on this framework.
Value Proposition
The skin is an ideal mediator of vaccines, because it contains a powerful network of immune cells which act as the body’s primary barrier against infection. The TransVac™ delivery of immunogens via the skin thus mimics natural infections, leading to effective immune responses.
Additional Information